hemophagocytic lymphohistiocytosis

Showing 1 - 25 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Segmental Resection Combined With DEP Regimen for EBV-HLH

Not yet recruiting
  • Hemophagocytic Lymphohistiocytosis
  • +2 more
  • Segmental bowel resection combined with the DEP regimen
  • Beijing, Beijing, China
    Zhao Wang
Nov 9, 2023

Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

Not yet recruiting
  • Refractory
  • +2 more
  • GTP regimen
  • (no location specified)
Sep 8, 2023

PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

Not yet recruiting
  • PD-1 Antibody
  • +3 more
  • L-DEP and PD-1 antibody
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Mar 8, 2023

Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Phoenix, Arizona
  • +9 more
Jan 9, 2023

Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

Completed
  • Hemophagocytic Lymphohistiocytosis
  • +5 more
  • Hematopoietic Stem Cell Transplant
  • Birmingham, Alabama
  • +21 more
Dec 6, 2022

Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Sep 15, 2022

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

    Recruiting
    • Immune Deficiency Disorders
    • +13 more
    • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
    • Saint Louis, Missouri
      Washington University
    Apr 25, 2022

    Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

    Not yet recruiting
    • Hemophagocytic Lymphohistiocytosis
    • L-DEP and PD-1 antibody
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Apr 19, 2022

    Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

    Withdrawn
    • Hemophagocytic Lymphohistiocytosis
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 11, 2022

    Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)

    Recruiting
    • Hemophagocytic Lymphohistiocytosis
    • DEP combine with PD-1 antibody
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Feb 13, 2022

    Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)

    Recruiting
    • Chidamide
    • Hemophagocytic Lymphohistiocytosis
    • Chidamide combines with VP-16 and methylprednisolone
    • Beijing, Beijing, China
      Beijing Friendship Hospital
    Nov 29, 2021

    Adult Hemophagocytic Lymphohistiocytosis in Critically Ill

    Recruiting
    • Hemophagocytic Lymphohistiocytosis
      • Berlin, Germany
        Department of Anesthesiology and Operative Intensive Care Medici
      Jul 13, 2021

      Hemophagocytic Lymphohistiocytosis Trial in Canada, United States (ATG, rabbit, Etoposide, Methotrexate)

      Completed
      • Hemophagocytic Lymphohistiocytosis
      • ATG, rabbit
      • +4 more
      • Phoenix, Arizona
      • +14 more
      Sep 21, 2020

      Interferon Gamma and Other Inflammatory Mediators in

      Completed
      • Hemophagocytic Lymphohistiocytosis
      • Blood Draws
      • Data Collection
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Mar 16, 2020

      Hurler Syndrome, Fanconi Anemia, Glanzmann Thrombasthenia Trial in Atlanta (Abatacept)

      Completed
      • Hurler Syndrome
      • +14 more
      • Atlanta, Georgia
        Children's Healthcare of Atlanta
      Dec 20, 2019

      Hemophagocytic Lymphohistiocytosis Trial in Beijing (low dose ruxolitinib, high dose ruxolitinib)

      Unknown status
      • Hemophagocytic Lymphohistiocytosis
      • low dose ruxolitinib
      • high dose ruxolitinib
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Oct 27, 2019

      Hemophagocytic Lymphohistiocytosis Trial in Beijing (Pegylated liposomal doxorubicin, Etoposide, Methylprednisolone)

      Unknown status
      • Hemophagocytic Lymphohistiocytosis
      • Pegylated liposomal doxorubicin
      • +2 more
      • Beijing, China
        Beijing Friendship Hospital
      Sep 4, 2019

      Ferritin in Critically Ill Special Focus on Underlying

      Completed
      • Hemophagocytic Lymphohistiocytosis
        • (no location specified)
        Aug 19, 2019

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (Ruxolitinib, Dexamethasone)

        Unknown status
        • Hemophagocytic Lymphohistiocytosis
        • Beijing, Chaoyang District, China
        • +1 more
        Jan 5, 2019

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (Etoposide, Dexamethasone, IVIG)

        Unknown status
        • Hemophagocytic Lymphohistiocytosis
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Nov 13, 2018

        Hemophagocytic Lymphohistiocytosis Trial in Seoul (IST and/or alloHCT)

        Terminated
        • Hemophagocytic Lymphohistiocytosis
        • IST and/or alloHCT
        • Seoul, Korea, Republic of
          Asan Medical center, University of Ulsan College of Medicine
        Jul 19, 2018

        Hemophagocytic Lymphohistiocytosis Trial in Stockholm (Dexamethasone, Etoposide, Cyclosporin)

        Completed
        • Hemophagocytic Lymphohistiocytosis
        • Stockholm, Sweden
          Childhood Cancer Research Unit, Karolinska Hospital
        Jul 2, 2018

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP-Ru)

        Unknown status
        • Hemophagocytic Lymphohistiocytosis
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        May 26, 2018